Life Stem Genetics, Inc. engages in the operation of stem cell therapy-based clinics. The company is headquartered in Beverly Hills, California and currently employs 1 full-time employees. The company went IPO on 2013-04-11. The firm is exploring to engage in cell therapy research and life science in general.
LIFS stock price ended at $0 on 金曜日, after rising NaN%
On the latest trading day Jan 02, 2026, the stock price of LIFS rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 580 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 980 shares were traded, equating to a market value of approximately --.